What is NDC 72162-2361?

72162-2361 is the product NDC for Zafirlukast, Zafirlukast 20 mg/1 tablet, film coated, listed with the FDA by Bryant Ranch Prepack. It has 1 package NDC, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 72162. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Zafirlukast?

11 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Zafirlukast NDC 72162-2361 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-2361Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-2361Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-2361-6	72162236106	60 TABLET, FILM COATED in 1 BOTTLE (72162-2361-6)Marketed from Jun 28, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zafirlukast
Generic name (nonproprietary): zafirlukast
Active ingredients: Zafirlukast — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 72162
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212475
Marketing start: Sep 10, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 2C9 Inhibitors (Mechanism)Leukotriene Receptor Antagonists (Mechanism)
Identifiers: Product ID 72162-2361_50679c31-2161-47a0-a704-13a01760fdbfSPL ID 50679c31-2161-47a0-a704-13a01760fdbfSPL set ID d2256673-fe8b-4fba-a73a-a81e24e47cf8RxCUI 199655UNII XZ629S5L50
Pharmacologic class: Leukotriene Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162236106 followed by a unit qualifier and the quantity

Package 72162-2361-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 28, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72162-2361

What is NDC 72162-2361?: 72162-2361 is the product NDC for Zafirlukast, Zafirlukast 20 mg/1 tablet, film coated, listed with the FDA by Bryant Ranch Prepack. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Zafirlukast.
What is the active ingredient?: Zafirlukast.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 72162. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Zafirlukast?: 11 other product NDCs are listed under this name. See all Zafirlukast NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Zafirlukast NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Zafirlukast	Zafirlukast 10 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-291	59651-0291-60
Zafirlukast	Zafirlukast 20 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-292	59651-0292-60
Zafirlukast	Zafirlukast 10 mg/1	Tablet, CoatedOral	AvKARE	42291-970	42291-0970-60
Zafirlukast	Zafirlukast 20 mg/1	Tablet, CoatedOral	AvKARE	42291-971	42291-0971-60
Zafirlukast	Zafirlukast 10 mg/1	Tablet, CoatedOral	Strides Pharma Science Limited	64380-187	64380-0187-01
Zafirlukast	Zafirlukast 20 mg/1	Tablet, CoatedOral	Strides Pharma Science Limited	64380-188	64380-0188-01
Zafirlukast	Zafirlukast 10 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-007	31722-0007-0131722-0007-0531722-0007-60
Zafirlukast	Zafirlukast 20 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-008	31722-0008-0131722-0008-0531722-0008-60
Zafirlukast	Zafirlukast 20 mg/1	Tablet, Film coatedOral	American Health Packaging	68084-059	68084-0059-21
Zafirlukast	Zafirlukast 10 mg/1	Tablet, Film coatedOral	Dr. Reddys Laboratories Limited	55111-625	55111-0625-0155111-0625-0555111-0625-30+2 more

All 12 Zafirlukast NDCs

Other NDCs under ANDA 212475

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212475
Product	Strength	Form · route	Labeler	Product NDC
Zafirlukast	Zafirlukast 10 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-007
Zafirlukast	Zafirlukast 20 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-008